Moderna, Inc. (MRNA) announced on Tuesday that it has been awarded a $176 million project grant through the Rapid Response Partnership Vehicle, funded by BARDA within the U.S. Department of Health and Human Services to expedite the development of mRNA-based pandemic influenza vaccines.
The company said that this funding will support the advanced stages of development for an mRNA-based vaccine intended for the licensure of a pre-pandemic vaccine targeting the H5 influenza virus, which is known to cause a highly contagious and severe disease in birds and poses a potential risk of transmission to humans.
The agreement also includes provisions for preparing and expediting responses to future public health crises.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.